Ledger.Open graph →
SEC Form D · filed December 31, 2014

PIERIS PHARMACEUTICALS, INC

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Freising-Weihenstephan, 2M
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Christina M. Takke · Freising-Weihenstephan, 2MDirectorChau M. Khuong · Freising-Weihenstephan, 2MDirectorStephen S. Yoder · Freising-Weihenstephan, 2MExec · DirectorSteven M. Prelack · Freising-Weihenstephan, 2MDirectorMichael M. Richman · Freising-Weihenstephan, 2MDirectorDarlene M. Deptula-Hicks · Freising-Weihenstephan, 2MExecXin N. Xu · Grand Cayman, Cayman IslandsDirectorGeoffrey D. Strong · New York, NYExec · DirectorDaren Heitman · Berwyn, PAExec · DirectorRedwood Capital Management, LLC · Englewood Cliffs, NJDirectorCraig Siegler · Chicago, ILDirectorPaul Williams · McKinney, TXExec · DirectorMilton Glenn · McKinney, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗